qrelabrutinib
Showing 1 - 1 of 1
Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)
Not yet recruiting
- Chronic Primary Immune Thrombocytopenia (ITP)
- Qrelabrutinib
- Placebo
-
Bengbu, Anhui, China
- +13 more
Aug 15, 2023